cognitive cybersecurity intelligence

News and Analysis

Search

These Are 2 of The Biggest Issues with Healthcare AI, According to an FDA Reviewer

Luke Ralston, a biomedical engineer and scientific reviewer at the FDA, has emphasised the need for transparency in AI regulation. The two main issues hampering the regulation are performance drift and data generalisation. Ralston stated that AI companies need to start monitoring and tracking the performance of their products once deployed and they also need to expand its representative data to cover more than just the demographics.

Source: medcitynews.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

What the US Election Means for Drug Pricing

The global medical technology, biotech, and life sciences industries face challenges from economic uncertainty, geopolitical tensions, and evolving regulations. Despite pandemic aftereffects, patent expirations, and